Valachis Antonis - Department of Immunology, Genetics, and Pathology, Uppsala University

基本信息

浏览量：11

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 143 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Moderately Hypofractionated Prostate-Only Versus Whole-Pelvis Radiotherapy for High-Risk Prostate Cancer: A Retrospective Real-World Single-Center Cohort Study

Jenny Kahlmeter Brandell,Antonis Valachis,Henrik Ugge,Daniel Smith,Bengt Johansson

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2024)

引用0浏览0WOS引用

Implementing Geriatric Assessment for Dose Optimization of CDK4/6 Inhibitors in Older Breast Cancer Patients

Antonis Valachis,Laura Biganzoli,Athina Christopoulou,Kamilla Fjermeros, Elena Fountzila,Jurgen Geisler,Raquel Gomez-Bravo,Peeter Karihtala,Paris Kosmidis,Angelos Koutras,Helena Linardou,Henrik Lindman, Ivan Martinez-Ballestero, Anna Belen Rodriguez,Icro Meattini,Montserrat Munoz-Mateu, Mukhrizah Othman,Amanda Psyrri,Emanuela Risi,Aglaia Schiza, Nikolaos Spathas,Meri Utriainen,Luca Visani, Soledad Ballesteros, Ioannis Basdekis, Susanne Dieroff Hay, Theo Fotis, Samuel Fricker, Gimon de Graaf, Marit Jenset, Tim Kanters, Kostas Lampropoulos, Christiana Markou, Kalliopi Mastoraki, Christina Nanou, Jose Manuel Reales Aviles, Marianne Santaholma,Thanos Kosmidis

Future oncology (London, England)no. 37 (2024): 2937-2948

引用0浏览0WOS引用

Abstract PO3-01-04: Neoadjuvant Compared to Adjuvant Chemotherapy Combined with Trastuzumab in Patients with HER2-positive Breast Cancer: a Register-Based Cohort Study

Servah Hosseini-Mellner,Åsa Wickberg,Antonis Valachis,Andreas Karakatsanis

Cancer Researchno. 9_Supplement (2024): PO3-01

引用0浏览0引用

Abstract PO4-17-04: CDK 4/6 Inhibitor Switching Patterns in Swedish Patients with Metastatic Breast Cancer: 5-Year Update from the SIRI Study

Henrik Lindman,Antonis Valachis,Rosa Lauppe,Mathias Lilja,Daniel Nyqvist, Maria Jakobsson

Cancer Researchno. 9_Supplement (2024): PO4-17

引用0浏览0引用

Abstract PO4-15-05: Genomic characterization and molecular predictive biomarkers for chemotherapy in a real-world population with metastatic triple-negative breast cancer

Erik Olsson,Henrik Lindman,Evangelos Digkas,Viktoria Thurfjell, Haidar Mir Ali,Ute Krüger,Anna-Karin Wennstig,Marie Sundqvist,Antonis Valachis

Cancer Researchno. 9_Supplement (2024): PO4-15

引用0浏览0引用

Multiple Immune-Related Adverse Events Secondary to Checkpoint Inhibitor Therapy in Patients with Advanced Cancer: Association with Treatment Effectiveness

Cecilia Olsson Ladjevardi,Anthoula Koliadi,Viktoria Ryden, Ali Inan El-Naggar,Evangelos Digkas,Antonios Valachis,Gustav J. Ullenhag

FRONTIERS IN ONCOLOGY (2024)

引用0浏览0WOS引用

The Role of Dacarbazine and Temozolomide Therapy after Treatment with Immune Checkpoint Inhibitors in Malignant Melanoma Patients: A Case Series and Meta-Analysis

Viktoria Ryden, Ali Inan El-Naggar,Anthoula Koliadi,Cecilia Olsson Ladjevardi,Evangelos Digkas,Antonios Valachis,Gustav J. Ullenhag

PIGMENT CELL & MELANOMA RESEARCHno. 3 (2024)

引用0浏览0WOS引用

Intraoperative Radiation Therapy Delivered by Brachytherapy in Breast Cancer: an Interim Analysis of a Phase 2 Trial

Asa Wickberg, Clara Prag,Antonis Valachis,Leif Karlsson,Bengt Johansson

CLINICAL BREAST CANCERno. 3 (2024): 243-252

引用0浏览0WOS引用

Outcomes of Preoperative MRI for Breast Cancer. A Meta-Analysis of Randomized Controlled Trials

Andreas Karakatsanis,Eirini Pantiora, Linda Olsson, Nazia Riaz,Antonios Valachis,Athanasios Zouzos, Eriksson Jonathan,Staffan Eriksson

European Journal of Surgical Oncologyno. 2 (2024): 107374

引用0浏览0引用

Towards Optimal Learning: Investigating the Impact of Different Model Updating Strategies in Federated Learning

Mihailo Ilic,Mirjana Ivanovic,Vladimir Kurbalija,Antonios Valachis

EXPERT SYSTEMS WITH APPLICATIONS（2024）

引用0浏览0EI引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn